Person:
Echeverz SarasĂșa, Maite

Profile Picture

Email Address

person.page.identifierURI

https://academica-e.unavarra.es/handle/2454/48933

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

Echeverz SarasĂșa

First Name

Maite

person.page.departamento

Ciencias de la Salud

person.page.instituteName

ORCID

0000-0002-4153-4549

person.page.upna

810062

Name

Filters

20161
Reset filters

Settings

Has files: true × Author: Latasa Osta, Cristina × Subject: Antibodies ×

Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    PublicationOpen Access
    Evaluation of a Salmonella strain lacking the secondary messenger c-di-GMP and RpoS as a live oral vaccine
    (Public Library of Science, 2016) Latasa Osta, Cristina; Echeverz SarasĂșa, Maite; GarcĂ­a Ona, Enrique; Burgui Erice, Saioa; Casares, Noelia; HervĂĄs Stubbs, Sandra; Lasarte, Juan JosĂ©; Lasa Uzcudun, ĂĂ±igo; Solano Goñi, Cristina; GarcĂ­a MartĂ­nez, Begoña; Gil Puig, Carmen; IdAB. Instituto de AgrobiotecnologĂ­a / Agrobioteknologiako Institutua; Gobierno de Navarra / Nafarroako Gobernua: IIM 13329.RI1
    Salmonellosis is one of the most important bacterial zoonotic diseases transmitted through the consumption of contaminated food, with chicken and pig related products being key reservoirs of infection. Although numerous studies on animal vaccination have been performed in order to reduce Salmonella prevalence, there is still a need for an ideal vaccine. Here, with the aim of constructing a novel live attenuated Salmonella vaccine candidate, we firstly analyzed the impact of the absence of cyclic-di-GMP (c-di-GMP) in Salmonella virulence. Cdi-GMP is an intracellular second messenger that controls a wide range of bacterial processes, including biofilm formation and synthesis of virulence factors, and also modulates the host innate immune response. Our results showed that a Salmonella multiple mutant in the twelve genes encoding diguanylate cyclase proteins that, as a consequence, cannot synthesize c-di-GMP, presents a moderate attenuation in a systemic murine infection model. An additional mutation of the rpoS gene resulted in a synergic attenuating effect that led to a highly attenuated strain, referred to as ΔXIII, immunogenic enough to protect mice against a lethal oral challenge of a S. Typhimurium virulent strain. ΔXIII immunogenicity relied on activation of both antibody and cell mediated immune responses characterized by the production of opsonizing antibodies and the induction of significant levels of IFN-Îł, TNF- α, IL-2, IL-17 and IL-10. ΔXIII was unable to form a biofilm and did not survive under desiccation conditions, indicating that it could be easily eliminated from the environment. Moreover, ΔXIII shows DIVA features that allow differentiation of infected and vaccinated animals. Altogether, these results show ΔXIII as a safe and effective live DIVA vaccine